Is polyvinylpyrrolidone (PVP) used in Intravenous (IV) tubing and hemodialysis line tubing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Use of Polyvinylpyrrolidone in IV Tubing and Hemodialysis Line Tubing

Yes, polyvinylpyrrolidone (PVP) is used in both IV tubing and hemodialysis line tubing as a hydrophilic modifier to improve biocompatibility and reduce adverse reactions.

PVP in Hemodialysis Membranes and Tubing

Role and Function

  • PVP serves as a hydrophilic modifier in synthetic dialysis membranes to increase biocompatibility 1
  • It is specifically used to coat polyurethane hemodialysis catheters and tubing to improve hemocompatibility 2
  • PVP content varies between commercially available dialyzers, with polysulfone-based membranes typically containing higher amounts (up to 26.3%) compared to polyethersulfone-based membranes (as low as 15.6%) 1

Benefits in Hemodialysis Applications

  • Reduces platelet loss during dialysis, which is a marker of improved biocompatibility 1
  • Decreases protein adsorption on membrane surfaces
  • Inhibits platelet adhesion and deformation
  • Prolongs activated partial thromboplastin time (APTT) and prothrombin time (PT) 3
  • Decreases fibrinogen conversion to fibrin, reducing clotting risks 3

Potential Concerns

  • PVP may be eluted into the patient's blood during dialysis, which has been discussed as a possible cause for rare adverse reactions 1
  • Elution rates vary by sterilization method:
    • Autoclave steam-sterilized membranes show higher PVP elution (up to 9.1 mg/1.6 m² dialyzer)
    • INLINE steam sterilized membranes show minimal elution (<0.5 mg/1.6 m² dialyzer) 1

PVP in IV Tubing

Applications

  • PVP is used as a coating agent for IV tubing, particularly for polyurethane catheters 2
  • It serves as a lubricant for polyurethane enteral feeding tubes, which has implications for medication administration through these tubes 2
  • PVP is preferred over other materials due to its low toxicity, chemical stability, and good biocompatibility 4

Advantages

  • Hemocompatible and physiologically inactive properties make it suitable for blood-contacting applications 4
  • Prevents nonspecific protein adsorption on surfaces, reducing thrombogenic potential 4
  • Serves as an effective antifouling surface modifier comparable to poly(ethylene glycol) (PEG) 4

Material Considerations and Alternatives

Material Comparisons

  • Polytetrafluoroethylene (Teflon) and polyurethane catheters have been associated with fewer infectious complications than catheters made of polyvinyl chloride (PVC) or polyethylene 2
  • For enteral feeding tubes, polyurethane tubes maintain better patency compared to silicone tubes when medications are administered 5

Alternative Materials

  • Some facilities are transitioning away from PVC tubing containing DEHP (di-2-ethylhexyl phthalate), particularly in neonatal intensive care units, due to potential health concerns 6
  • Anti-infective agents used in conjunction with central venous catheters include combinations of minocycline and rifampin or silver and chlorhexidine, which have been shown to reduce catheter-related bloodstream infections 2

Clinical Implications

Infection Prevention

  • The use of PVP-coated materials may contribute to infection prevention strategies in dialysis settings, where catheter-related infections are a significant concern 2
  • Proper care of catheters and tubing, including appropriate hand hygiene and PPE use, remains essential regardless of material composition 2

Medication Administration

  • When administering medications through PVP-lubricated tubes, be aware that some drugs (like phenytoin) may bind to the PVP coating, potentially affecting drug delivery 2
  • Flush tubes with at least 30 mL of water before, between, and after medication administration to maintain patency 2, 5

PVP continues to be an important component in medical tubing due to its favorable biocompatibility profile, though ongoing research explores ways to optimize its performance and minimize potential adverse effects.

References

Research

Polyvinylpyrrolidone in hemodialysis membranes: Impact on platelet loss during hemodialysis.

Hemodialysis international. International Symposium on Home Hemodialysis, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Enteral Feeding Tube Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.